Pyridone derivatives and process for preparing the same

a technology of pyridone and derivatives, applied in the field of pyridone derivatives, can solve the problems of unsuitable large-scale production with respect to safety and explosion risk, and achieve the effects of improving the yield of reaction, facilitating reaction, and proceeding quickly

Inactive Publication Date: 2001-12-13
SUMITOMO DAINIPPON PHARMA CO LTD
View PDF0 Cites 29 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Benefits of technology

0166] When the amine derivative (3) is used in the form of an acid addition salt thereof, the reaction may smoothly proceed by converting the compound (3) into a free form, if necessary. In this case, an agent for converting the compound (3) into a free form is preferably a tertiary amine such as triethylamine, etc., or pyridine, etc.
0167] On the other hand, the carbamoylpyridone derivative (1) is converted into the isocyanate derivative (2) by reacting it with a hypochlorite or a hypobromite in an amount of 1 to 10 mole equivalents, preferably in an amount of 1 to 5 mole equivalent in a mixed solvent of water and an organic solvent at a temperature of from 0.degree. C. to 80.degree. C., preferably at a temperature of from room temperature to 50.degree. C., and then further reacted with the amine derivative (3) in an amount of 1 to 3 mole equivalents, preferably in an amount of 1 to 1.5 mole equivalent, to give the pyridone derivative (4). When the isocyanate derivative (2) is prepared, the reaction may proceed quickly by addition of a phase transfer catalyst in an amount of 0.05 to 0.2 mole equivalent. The phase transfer catalyst is preferably tetrabutylammonium hydrogen sulfate. The preferable hypochlorite or hypobromite is sodium hypobromite. The sodium hypobromite is usually prepared from aqueous sodium hydroxide solution and bromine at 0.degree. C. to 10.degree. C. in the reaction system. The organic solvent may be any solvent which does not disturb the reaction, for example, ethers (e.g., dimethoxyethane, tetrahydrofuran, dioxane, etc), aromatic hydrocarbons (e.g., benzene, toluene, xylene, etc.), halogenated hydrocarbons (e.g., dichloromethane, chloroform, dichloroethane, chlorobenzene, dichlorobenzene, etc.), and amides (e.g., N,N-dimethylformamide, N,N-dimethylacetamide, etc.). When the isocyanate derivative (2) is reacted with the amine derivative (3), the yield of the reaction may be improved by addition of acetic acid in a volume of 10 to 30% of the volume of the reaction solvent.

Problems solved by technology

However, the present inventors have found that the azidating agents used in the above process and the compounds prepared by azidating the carboxyl derivative of the formula (II) have a risk of explosion and therefore, they are not suitable for large-scale production with respect to safety.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Pyridone derivatives and process for preparing the same
  • Pyridone derivatives and process for preparing the same
  • Pyridone derivatives and process for preparing the same

Examples

Experimental program
Comparison scheme
Effect test

example 1

[0218] Preparation of N-[1-butyl-4-(3-methoxyphenyl)-1,2-dihydro-2-oxo-1,8--naphthyridin-3-yl]-N'-(2,6-diisopropylphenyl) urea: 58

[0219] To a suspension of 1-butyl-3-carbamoyl-4-(3-methoxyphenyl)-1,2-dihy-dro-2-oxo-1,8-naphthyridine (10.0 g, 27.2 mmol) in N,N-dimethylformamide (100 ml) was added lead tetracetate (14.5 g, 32.6 mmol), and the mixture was stirred at room temperature for 0.5 hour. Subsequently, to the mixture was added 2,6-diisopropylaniline (5.3 g, 30 mmol) at the same temperature, and the mixture was stirred at 40.degree. C. for 50.degree. C. for 1.5 hour. After allowed to cool, ethyl acetate (500 ml) was added to the mixture, and the mixture was filtered through a celite pad. The filtrate was washed successively with water, 4 N aqueous hydrochloric acid solution, water and a saturated aqueous sodium chloride solution, dried over magnesium sulfate, and concentrated under reduced pressure to the volume of about 100 ml. The resultant was stirred for 2 hours under coolin...

example 2

[0221] Preparation of N-[1-butyl-4-(3-methoxyphenyl)-1,2-dihydro-2-oxo-1,8--naphthyridin-3-yl]-N'-(2,6-diisopropylphenyl)urea: 59

[0222] To a 1 N aqueuos sodium hydroxide solution (48 ml, 48 mmol) was added dropwise bromine (1.2 ml, 24 mmol) under ice-cooling, and the mixture was stirred for 30 minutes. The pale yellow solution thus obtained was added dropwise to a suspension of 1-butyl-3-carbamoyl-4-(3-m-ethoxyphenyl)-1,2-dihydro-2-oxo-1,8-naphthyridine (2.1 g, 6 mmol) and tetrabutylammonium hydrogen sulfate (102 mg, 0.3 mmol) in toluene (210 ml) at room temperature, and the mixture was stirred at the same temperature for 4 hours. To the mixture was added a solution of acetic acid (35 ml) and 2,6-diisopropylaniline (1.6 g, 9.0 mmol) in toluene (35 ml) at room temperature, and the mixture was stirred at the same temperature for 1.5 hour. Water was added to the reaction solution, and the mixture was extracted with ethyl acetate, washed with water, washed with a saturated aqueous sodiu...

example 3

[0224] Preparation of 1-butyl-3-amino-4-(3-methoxyphenyl)-1,2-dihydro-2-ox-o-1,8-naphthyridine; 60

[0225] To a 1 N aqueous sodium hydroxide-solution (88 ml, 88 mmol) was added dropwise bromine (1.0 ml, 19.4 mmol) under ice-cooling, and the mixture was stirred for 30 minutes. The pale yellow solution thus obtained was added dropwise to a suspension of 1-butyl-3-carbamoyl-4-(3-m-ethoxyphenyl)-1,2-dihydro-2-oxo- 1,8-naphthyridine (5.0 g, 14.2 ml) and tetrabutylammonium hydrogen sulfate (250 mg. 0.71 mmol) in tetrahydrofuran (500 ml) at room temperature, and the mixture was stirred at the same temperature for 6.5 hours. Water was added to the reaction solution, and the mixture was extracted with ethyl acetate, washed with water, washed with a saturated aqueous sodium chloride solution, dried over anhydrous magnesium sulfate, and concentrated under reduced pressure. To the concentrated residue was added 2-propanol (40 ml), and the mixture was stirred for 3 hours under ice-cooling. The pre...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

PropertyMeasurementUnit
weightsaaaaaaaaaa
temperatureaaaaaaaaaa
temperatureaaaaaaaaaa
Login to view more

Abstract

A process for preparing a pyridone derivative (4), which comprises reacting the compound (1) with a hypochlorite or a hypobromite or with lead tetraacetate to give the compound (2), and reacting the compound (2) with the compound (3). Said process is preferably especially from the standpoint of safety. wherein R1 is hydrogen, alkyl, substituted alkyl, etc.; Y1 is hydrogen, alky, substituted alky, etc.; Y2 and Y3 are indenpently hydrogen, halogen, etc.; and L is alkyl, substituted alkyl, etc.

Description

[0001] The present invention relates to a pyridone derivative or a salt thereof, which exhibits acyl-CoA: cholesterol acyl transferase (ACAT) inhibitory activity, and is useful as an agent for treatment of hyperlipidemia and atherosclerosis, and a process for preparing the same.PRIOR ART[0002] Cerebral vessel disorders such as stroke, and myocardial infarction, which rank in high in causes of death in developed countries, break out with being accompanied by atherosclerosis as basal disease. From the results of epidemiology research, it is pointed out that hypercholesterolemia is one of risk factors for atherosclerosis, and there are mainly used anti-hyperlipidemic agents, which can reduce cholesterol level in blood, in the prophylaxis or treatment thereof. However, there is no sufficiently effective agent in terms of the efficacy thereof. Recently, it is observed that cells derived from macrophage accumulate cholesterol ester droplet within the cells and become foam cells in atheros...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(United States)
IPC IPC(8): C07D213/73C07D213/75C07D471/04C07D521/00
CPCC07D213/73C07D213/75C07D231/12C07D233/56C07D249/08C07D471/04
Inventor MURAOKA, MASAMIMORISHITA, KOJIAIDA, NAGISATANAKA, MASASHIYURI, MASATOSHIOHASHI, NAOHITO
Owner SUMITOMO DAINIPPON PHARMA CO LTD
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap